Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $85
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a Buy rating on Merit Medical Systems (MMSI) but lowers the price target from $88 to $85.

May 01, 2024 | 11:24 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham maintains a Buy rating on Merit Medical Systems but lowers the price target from $88 to $85.
The adjustment in price target by Needham reflects a slight change in valuation expectation for Merit Medical Systems, likely due to updated financial analysis or market conditions. However, maintaining a Buy rating indicates a positive outlook on the company's fundamentals and growth prospects. The reduction in price target might have a neutral to slightly negative short-term impact on the stock price as it adjusts to the new analyst expectations.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100